Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Dosing in Elderly RALP
NCT04854993Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Policlinico Gemelli. Started Jul 2021; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT04854993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04854993.